The use of novel antineoplastic agents to inhibit the growth and metastasis of malignant melanoma and other cancers.
Olden
K
K
Howard University Cancer Center, Howard University College of Medicine, Washington, DC 20060.
Newton
S A
SA
Nagai
T
T
Yasuda
Y
Y
Grzegorzewski
K
K
Breton
P
P
Oredipe
O
O
White
S L
SL
D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D005109:Extracellular Matrix / Q000378:metabolism; D005353:Fibronectins / Q000502:physiology; D006031:Glycosylation / Q000187:drug effects; D007212:Indolizines / Q000494:pharmacology / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D008565:Membrane Proteins / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009363:Neoplasm Proteins / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use*; D009844:Oligosaccharides / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D017026:Swainsonine / Q000494:pharmacology / Q000627:therapeutic use*; D054836:Indolizidines
D000970:Antineoplastic Agents; D005353:Fibronectins; D007212:Indolizines; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D009842:Oligopeptides; D009844:Oligosaccharides; D017026:Swainsonine; C049554:glycyl-arginyl-glycyl-aspartyl-serine; C037806:castanospermine; D054836:Indolizidines